B-natriuretic peptide serum levels in neonates with persistent pulmonary hypertension
Open Access
- 19 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Egyptian Pediatric Association Gazette
- Vol. 69 (1), 1-8
- https://doi.org/10.1186/s43054-021-00058-y
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- B-Type Natriuretic Peptide and Rebound during Treatment for Persistent Pulmonary HypertensionThe Journal of Pediatrics, 2012
- B-Type Natriuretic Peptide Assay for the Diagnosis and Prognosis of Patent Ductus Arteriosus in Preterm InfantsKorean Circulation Journal, 2012
- A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newbornJournal of Perinatology, 2011
- BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infantsEarly Human Development, 2010
- Advances in the Diagnosis and Management of Persistent Pulmonary Hypertension of the NewbornPediatric Clinics of North America, 2009
- Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2009
- Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?Archives of Disease in Childhood: Fetal & Neonatal, 2007
- Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded StudyPEDIATRICS, 2006
- The Use of a Bedside Assay for Plasma B-type Natriuretic Peptide as a Biomarker in the Management of Patent Ductus Arteriosus in Premature NeonatesThe Journal of Pediatrics, 2005
- Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the NewbornPEDIATRICS, 2004